Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:51:18 +0200Fri, 01 Mar 2024 15:26:00 +0100Human medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/rxultiHuman medicines European public assessment report (EPAR): Rxulti, brexpiprazole, Date of authorisation: 26/07/2018, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/rxultiFri, 01 Mar 2024 15:26:00 +0100Human medicineRxulti : EPAR - All authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-3841-aa_en.pdfRxulti : EPAR - All authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/ema-other-h-3841-aa_en.pdfWed, 01 Dec 2021 15:11:00 +0100Human medicine